These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18180010)

  • 1. Impact on hospital policy: Yale experience.
    Weinreb JC
    J Am Coll Radiol; 2008 Jan; 5(1):53-6. PubMed ID: 18180010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephrogenic systemic fibrosis: an overview.
    Cowper SE
    J Am Coll Radiol; 2008 Jan; 5(1):23-8. PubMed ID: 18180005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephrogenic systemic fibrosis: a dermatologist's perspective.
    Girardi M
    J Am Coll Radiol; 2008 Jan; 5(1):40-4. PubMed ID: 18180008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction to this issue on NSF.
    Weinreb JC
    J Am Coll Radiol; 2008 Jan; 5(1):21-2. PubMed ID: 18180004
    [No Abstract]   [Full Text] [Related]  

  • 5. The impact of NSF on the care of patients with kidney disease.
    Abu-Alfa A
    J Am Coll Radiol; 2008 Jan; 5(1):45-52. PubMed ID: 18180009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating fibrocytes: cellular basis for NSF.
    Bucala R
    J Am Coll Radiol; 2008 Jan; 5(1):36-9. PubMed ID: 18180007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gadolinium-containing MRI contrast agents: important variations on a theme for NSF.
    Kuo PH
    J Am Coll Radiol; 2008 Jan; 5(1):29-35. PubMed ID: 18180006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephrogenic systemic fibrosis.
    Weinreb JC; Kuo PH
    Magn Reson Imaging Clin N Am; 2009 Feb; 17(1):159-67. PubMed ID: 19364606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadolinium-induced nephrogenic systemic fibrosis in patients with kidney and liver disease.
    Shenoy C
    Am J Med; 2008 Jan; 121(1):e11; author reply e13. PubMed ID: 18187056
    [No Abstract]   [Full Text] [Related]  

  • 10. [Nephrogenic systemic fibrosis].
    Breitschaft A; Stahlmann R
    Med Monatsschr Pharm; 2009 Oct; 32(10):377-82. PubMed ID: 19886227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue distribution and kinetics of gadolinium and nephrogenic systemic fibrosis.
    Abraham JL; Thakral C
    Eur J Radiol; 2008 May; 66(2):200-7. PubMed ID: 18374532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrogenic systemic fibrosis--implications for nephrologists.
    Saab G; Abu-Alfa A
    Eur J Radiol; 2008 May; 66(2):208-12. PubMed ID: 18342470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrogenic systemic fibrosis after exposure to gadolinium in patients with renal failure.
    Othersen JB; Maize JC; Woolson RF; Budisavljevic MN
    Nephrol Dial Transplant; 2007 Nov; 22(11):3179-85. PubMed ID: 17890246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrogenic systemic fibrosis: experimental studies confound prevailing theory of free gadolinium as a causative factor.
    Jakobsen J
    Acta Radiol; 2008 Jul; 49(6):616-7. PubMed ID: 18568551
    [No Abstract]   [Full Text] [Related]  

  • 15. Nephrogenic systemic fibrosis: pathogenesis, diagnosis, and therapy.
    Kribben A; Witzke O; Hillen U; Barkhausen J; Daul AE; Erbel R
    J Am Coll Cardiol; 2009 May; 53(18):1621-8. PubMed ID: 19406336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gadolinium and nephrogenic systemic fibrosis: association or causation.
    Kurtkoti J; Snow T; Hiremagalur B
    Nephrology (Carlton); 2008 Jun; 13(3):235-41. PubMed ID: 18221255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and histological findings in nephrogenic systemic fibrosis.
    Cowper SE; Rabach M; Girardi M
    Eur J Radiol; 2008 May; 66(2):191-9. PubMed ID: 18325705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gadolinium-induced nephrogenic systemic fibrosis in a patient with an acute and transient kidney injury.
    Kalb RE; Helm TN; Sperry H; Thakral C; Abraham JL; Kanal E
    Br J Dermatol; 2008 Mar; 158(3):607-10. PubMed ID: 18076707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety update on the possible causal relationship between gadolinium-containing MRI agents and nephrogenic systemic fibrosis.
    Pedersen M
    J Magn Reson Imaging; 2007 May; 25(5):881-3. PubMed ID: 17457808
    [No Abstract]   [Full Text] [Related]  

  • 20. Nephrogenic system fibrosis: a radiologist's practical perspective.
    Martin DR
    Eur J Radiol; 2008 May; 66(2):220-4. PubMed ID: 18321672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.